PL422751A1 - Method for determining the risk of cancers in women, depending on their age and concentration of chosen microelements - Google Patents
Method for determining the risk of cancers in women, depending on their age and concentration of chosen microelementsInfo
- Publication number
- PL422751A1 PL422751A1 PL422751A PL42275117A PL422751A1 PL 422751 A1 PL422751 A1 PL 422751A1 PL 422751 A PL422751 A PL 422751A PL 42275117 A PL42275117 A PL 42275117A PL 422751 A1 PL422751 A1 PL 422751A1
- Authority
- PL
- Poland
- Prior art keywords
- age
- risk
- women
- depending
- determining
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 abstract 2
- 108091007743 BRCA1/2 Proteins 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 229910052785 arsenic Inorganic materials 0.000 abstract 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229910052793 cadmium Inorganic materials 0.000 abstract 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 229940125697 hormonal agent Drugs 0.000 abstract 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 abstract 1
- 229910052753 mercury Inorganic materials 0.000 abstract 1
- 239000011785 micronutrient Substances 0.000 abstract 1
- 235000013369 micronutrients Nutrition 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 229910052711 selenium Inorganic materials 0.000 abstract 1
- 239000011669 selenium Substances 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Przedmiotem zgłoszenia jest sposób określania ryzyka raków u kobiet w zależności od ich wieku oraz stężeń wybranych mikroelementów. Ustalono, że istnieje korelacja między stężeniem arsenu, kadmu, ołowiu, rtęci, miedzi, cynku, selenu oraz ich wzajemnych stosunków stężeń we krwi pełnej a ryzykiem raków u kobiet nie będących nosicielkami żadnej z mutacji założycielskich w genie BRCA1/2 typowych dla populacji Polskiej zarówno przed jak i po 60 roku życia oraz w zależności od przyjmowania środków hormonalnych.The subject of the application is the method of determining the risk of cancer in women depending on their age and concentrations of selected micronutrients. It has been established that there is a correlation between the concentrations of arsenic, cadmium, lead, mercury, copper, zinc, selenium and their ratios in whole blood and the risk of cancer in women who are not carriers of any of the founder mutations in the BRCA1/2 gene typical of the Polish population, both before and after the age of 60 and depending on the use of hormonal agents.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL422751A PL422751A1 (en) | 2017-09-05 | 2017-09-05 | Method for determining the risk of cancers in women, depending on their age and concentration of chosen microelements |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL422751A PL422751A1 (en) | 2017-09-05 | 2017-09-05 | Method for determining the risk of cancers in women, depending on their age and concentration of chosen microelements |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL422751A1 true PL422751A1 (en) | 2019-03-11 |
Family
ID=65629587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL422751A PL422751A1 (en) | 2017-09-05 | 2017-09-05 | Method for determining the risk of cancers in women, depending on their age and concentration of chosen microelements |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL422751A1 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL397024A1 (en) * | 2011-11-17 | 2013-05-27 | Pomorski Uniwersytet Medyczny W Szczecinie | Method for determining the level of gastrointestinal cancer in the Polish population |
| PL414266A1 (en) * | 2015-10-05 | 2017-04-10 | Read-Gene Spółka Akcyjna | Concentration of selenium in blood as a risk factor for cancers in women |
-
2017
- 2017-09-05 PL PL422751A patent/PL422751A1/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL397024A1 (en) * | 2011-11-17 | 2013-05-27 | Pomorski Uniwersytet Medyczny W Szczecinie | Method for determining the level of gastrointestinal cancer in the Polish population |
| PL414266A1 (en) * | 2015-10-05 | 2017-04-10 | Read-Gene Spółka Akcyjna | Concentration of selenium in blood as a risk factor for cancers in women |
Non-Patent Citations (3)
| Title |
|---|
| FRITZ H. ET AL., SELENIUM AND LUNG CANCER: A SYSTEMATIC REVIEW AND META ANALYSIS, November 2011 (2011-11-01) * |
| LENER M. R. ET AL., CAN SELENIUM LEVELS ACT AS A MARKER OF COLORECTAL CANCER RISK?, 2013 * |
| RAYMAN M.P., SELENIUM AND HUMAN HEALTH, 2012 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY203469A (en) | Bcma/cd3 and gprdc5d/cd3 bispecific antibodies for use in cancer therapy | |
| MX2025002661A (en) | Anti-cd24 compositions and uses thereof | |
| PH12021550152A1 (en) | Anti-cd112r compositions and methods | |
| WO2019234241A8 (en) | ANTI-oxMIF/ANTI-CD3 ANTIBODY FOR CANCER TREATMENT | |
| ZA202004136B (en) | Use of chloroquine and clemizole compounds for treatment of inflammatory and cancerous conditions | |
| MX2019011148A (en) | Treatment methods. | |
| MX2018016183A (en) | Pd-l1-specific antibodies and methods of using the same. | |
| MX2021009514A (en) | Use of anti-ceacam5 immunoconjugates for treating lung cancer. | |
| NZ738875A (en) | Motile sperm domain containing protein 2 and cancer | |
| PL422751A1 (en) | Method for determining the risk of cancers in women, depending on their age and concentration of chosen microelements | |
| PL437046A1 (en) | Serum arsenic, zinc and selenium concentration as a marker of survival in patients with prostate cancer in Poland | |
| De Ruysscher | Radiotherapy and PD-L1 inhibition in metastatic NSCLC | |
| EA202190862A1 (en) | METHODS OF TREATMENT | |
| PL422750A1 (en) | Method for determining the risk of cancers in men, depending on their age and concentration of chosen microelements | |
| HK1259409A1 (en) | Therapeutic targeting of casein kinase 1 delta in breast cancer | |
| ATE478076T1 (en) | AZAXANTHONES FOR THE TREATMENT OF TUMORS | |
| NZ714014A (en) | Therapeutic effect prediction method for colorectal cancer patient in whom expression of tk1 protein has increased | |
| PL424468A1 (en) | How to determine the risk of cancer in women depending on the levels of arsenic and / or cadmium and / or zinc in the blood | |
| PL439315A1 (en) | The method of determining the risk of cancer in women depending on the concentration of selenium in the blood | |
| PL418719A1 (en) | Concentration of cadmium, lead and mercury in the full blood and the proportion of selenium content in the blood serum to the mentioned metals as a risk factor for women who are not the carriers of a mutation in BRCA1 gene | |
| Ebert et al. | Introduction to Genomics in Hematologic Malignancy | |
| PL414266A1 (en) | Concentration of selenium in blood as a risk factor for cancers in women | |
| Lorek et al. | Sentinel lymph node (sln) in breast cancer. Review of current identification methods | |
| Shibata et al. | MDSC (myeloid-derived suppressor cells) is an important immunosuppressing factor and functionally related with VEGF and IL-17 in patients with gastrointestinal cancer | |
| Kit et al. | Issues on classification of gastric neuroendocrine tumors |